Acute Stroke
Conditions
Keywords
tDCS, Acute Stroke, WMFT, SWMT, Fugl Meyer
Brief summary
40 acute subjects will be split into 5 groups. Each group will receive one of the following tDCS montages : anodal, bilateral, cathodal, extracephalic or placebo. Subjects will receive, in addition to conventional rehabilitation, 2mA for 20 mins of their attributed tDCS, 5 times a week. Evaluations will take place before the first stimulation period (48h post stroke), after 1, 2, 3 and 4 weeks. Evaluations consist of the Wolf Motor Function Test, the Fugl Meyer, and the Semmes Weinstein Monofilament Test
Detailed description
40 acute subjects will be randomized and split into 5 groups. Each group will receive one of the following tDCS montages : Anodal : Anode placer over the affected primary motor cortex, cathode over contralateral supra orbital area Bilateral : Anode placer over the affected primary motor cortex, cathode over unaffected motor cortex Cathodal : Cathode placer over the unaffected primary motor cortex, anode over contralateral supra orbital area Extracephalic : Anode placer over the affected primary motor cortex, cathode over right shoulder Placebo : anode montage but current is ramped up over 15 secondes, then ramped down. Subjects will receive, in addition to conventional rehabilitation (±1.5h/weekday), 2mA for 20 mins of their attributed tDCS, 5 times a week. Evaluations will take place before the first stimulation period (48h post stroke), after 1, 2, 3 and 4 weeks. Evaluations consist of the Wolf Motor Function Test, the Fugl Meyer, and the Semmes Weinstein Monofilament Test All researchers, therapists, data analysis and patients are blinded by a code system implemented in the tDCS machine
Interventions
Subjects received a micro-current through their scalp to induce cortical and subcortical changes
Sponsors
Study design
Masking description
Everyone is blinded, codes are selected by a third party not involved in any step of the study
Intervention model description
5 groups, each group receives one of four treatments or the sham treatment. Double-blinded, sham controlled study
Eligibility
Inclusion criteria
* First Ever Stroke * Motor or sensory deficit * Understands and follows orders * Signed inform consent
Exclusion criteria
* One Yes on the medium and high risk sections of the TSST (Bornheim et al.,2019)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Wolf Motor Function Test | Pre Stimulation (48 hours post stroke), Week 1, Week 2, Week 3, Week 4 | Functional upper limb test, filmed and scored subjectively |
| Change in Fugl Meyer Motor Assessment | Pre Stimulation (48 hours post stroke), Week 1, Week 2, Week 3, Week 4 | Functional upper limb, lower limb and sensory test |
| Change in Semmes Weinstein Monofilament Test | Pre Stimulation (48 hours post stroke), Week 1, Week 2, Week 3, Week 4 | 11 Point Sensory test |
Countries
Belgium